Noh J, Hamada N, Saito H, Yoshimoto M, Iwasaki H, Ozaki O, Okamoto Y, Ito K, Morii H
Ito Hospital, Tokyo, Japan.
Acta Endocrinol (Copenh). 1990 Nov;123(5):511-8. doi: 10.1530/acta.0.1230511.
Recently, thyroid microsomal antigen was identified as thyroid peroxidase, and thyroid microsomal antibody was found to inhibit thyroid peroxidase activity in vitro. We investigated the possibility that anti-microsomal antibody inhibits the iodination of tyrosine, in vivo. Immunoglobulin G with or without anti-microsomal antibody from hypothyroid patients with goitrous Hashimoto's thyroiditis inhibited thyroid hormone synthesis in cultured slices of normal human thyroid tissue. IgGs with anti-microsomal antibody inhibited 125I thyroidal uptake and thyroid hormone synthesis stimulated by TSH more than normal IgG did. However, the same results were obtained with IgGs without anti-microsomal antibody. This effect did not involve anti-microsomal antibody, anti-thyroglobulin antibody, TSH-binding inhibitor immunoglobulin, thyroid stimulation-blocking immunoglobulin, or the cAMP level of the thyroid tissue. The ratio of organic I to inorganic I with stimulation by TSH in slices incubated with IgG from hypothyroid patients with goitrous Hashimoto's thyroiditis or normal IgG was not significantly different, but was significantly higher in slices incubated with methylmercaptoimidazole. Therefore, IgG from hypothyroid patients with goitrous Hashimoto's thyroiditis mainly suppressed 125I thyroidal uptake, rather than inhibiting thyroid peroxidase activity. In addition, this IgG was present in the serum of 11 of the 12 hypothyroid patients with Hashimoto's thyroiditis studied. This IgG may be involved in the mechanism that causes hypothyroidism in some patients with goitrous Hashimoto's disease.
最近,甲状腺微粒体抗原被鉴定为甲状腺过氧化物酶,并且发现甲状腺微粒体抗体在体外可抑制甲状腺过氧化物酶的活性。我们研究了抗微粒体抗体在体内抑制酪氨酸碘化的可能性。来自患有甲状腺肿性桥本甲状腺炎的甲状腺功能减退患者的含有或不含有抗微粒体抗体的免疫球蛋白G,均可抑制正常人甲状腺组织培养切片中的甲状腺激素合成。含有抗微粒体抗体的免疫球蛋白G比正常免疫球蛋白G更能抑制促甲状腺激素(TSH)刺激的125I甲状腺摄取和甲状腺激素合成。然而,不含抗微粒体抗体的免疫球蛋白G也得到了相同的结果。这种作用不涉及抗微粒体抗体、抗甲状腺球蛋白抗体、TSH结合抑制免疫球蛋白、甲状腺刺激阻断免疫球蛋白或甲状腺组织的环磷酸腺苷(cAMP)水平。在与患有甲状腺肿性桥本甲状腺炎的甲状腺功能减退患者的免疫球蛋白G或正常免疫球蛋白G一起孵育的切片中,TSH刺激下有机碘与无机碘的比例没有显著差异,但在用甲基巯基咪唑孵育的切片中该比例显著更高。因此,患有甲状腺肿性桥本甲状腺炎的甲状腺功能减退患者的免疫球蛋白G主要抑制125I甲状腺摄取,而不是抑制甲状腺过氧化物酶的活性。此外,在所研究的12例桥本甲状腺炎甲状腺功能减退患者中,有11例患者的血清中存在这种免疫球蛋白G。这种免疫球蛋白G可能参与了某些甲状腺肿性桥本氏病患者发生甲状腺功能减退的机制。